You are currently on the new version of our website. Access the old version .
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Case Report
  • Open Access

18 August 2014

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) with Hard Palate and Bronchial Perforations Treated with Rituximab—A Case Report

,
,
,
,
,
and
II Department of Internal Medicine, Unit of Allergy and Clinical Immnology, Jagiellonian University, Medical College, ul. Skawińska 8, 31-066 Kraków, Poland
*
Author to whom correspondence should be addressed.

Abstract

We present a case of a 57-year-old woman suffering from granulomatosis with polyangiitis (GPA), who in the seventh months of immunosuppressive treatment (cyclophosphamide) progressed with new pulmonary changes and perforations of the hard palate and bronchi. Rituximab was introduced resulting in B-cell depletion and disappearance of anti-PR3 antibody. Palatal holes have substantially diminished and all bronchial perforations disappeared, covered by fibrous tissue. In the fourth month after rituximab administration, large scarring obstruction of the right main bronchus with upper and middle lobes atelectasis emerged. Because of increasing dyspnoea, stenotic bronchus was re-opened by bronchoscopy. Intervention was complicated by bilateral pneumothorax and later, on the seventh day, by fatal pulmonary bleeding. To our knowledge, this is the first report of GPA refractory to cyclophosphamide complicated by palatal and bronchial perforations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.